Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1)

Clinical trial NCT03392545 · UNKNOWN

Trial details

NCT number: NCT03392545
Sponsor: Beijing Tiantan Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

High Grade Glioma Glioblastoma Glioma of Brainstem Glioma, Malignant

Start date: 2018-04-01
Primary completion: 2020-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.